Journal article
Final 5-Year Follow-Up Results Evaluating Neoadjuvant Talimogene Laherparepvec Plus Surgery in Advanced Melanoma: A Randomized Clinical Trial
R Dummer, DE Gyorki, JR Hyngstrom, M Ning, T Lawrence, MI Ross
JAMA Oncology | Published : 2023
Abstract
This randomized clinical trial presents the final 5-year follow-up results of neoadjuvant talimogene laherparepvec (T-VEC) plus surgery in patients with advanced melanoma.
Grants
Funding Acknowledgements
The study was sponsored and funded by Amgen